Nabi Biopharmaceuticals (NABI)

Company

"Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and market products that fight serious medical conditions. The Company is focusing on developing products addressing commercial opportunities in its core business areas: Gram-positive bacterial infections, hepatitis, kidney disease (nephrology), and nicotine addiction. There are three products on the market today: PhosLo® (calcium acetate), Nabi-HB® [Hepatitis B Immune Globulin (Human)], and Aloprim™ (allopurinol sodium) for Injection and a number of products in various stages of clinical and preclinical development." (company website)

NABI 2-month stock chart

Buy

4-May-06. Not finding any promising buy candidates through my usual screens, I looked back at recent sells to see if there was anything that merited jumping back into. NABI seems to fill the bill. It has just bounced decisively off the 1-month average, and there are other positive signs in the chart.

  • Price momentum (PPO) — picking up again after slowing
  • Trend (ADX) — buying pressure (+DI) has just crossed back above selling pressure (-DI) again
  • Money flow (CMF) — very strong
  • Relative strength (RSI) — ticking up
  • Volume — generally bigger up days than down days

Sell

loss Bottom line
-18%

22-May-06. The market has been really unsettled lately, and I've watched the value of my portfolio fall. When things turned sour again this morning, I sold everything off and will take a time-out.

I expected NABI to hold at the 50-day moving average, but when it opened lower again this morning and continued to fall, I lost confidence.

NABI 1-year chart
NABI 1-year chart